EcoDrugPlus

Adrenoceptor Beta 1

Ensembl ID : ENSEEEG00000006184
Gene Symbol: ADRB1
4 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSEEEG00000002610
Gene Symbol: ADRB2A
4 Cross references
196 Possible Orthologues:

Adrenoceptor Beta 2, Surface B

Ensembl ID : ENSEEEG00000019275
Gene Symbol: ADRB2B
4 Cross references
150 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSEEEG00000001782
Gene Symbol: ADRB3A
4 Cross references
197 Possible Orthologues:

Adrenoceptor Beta 3b

Ensembl ID : ENSEEEG00000013279
Gene Symbol: ADRB3B
1 Cross references
146 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSEEEG00000010622
Gene Symbol: AKR1B1.2
4 Cross references
348 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSEEEG00000005594
Gene Symbol: GAA
4 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSEEEG00000023352
Gene Symbol: AOC1
4 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSEEEG00000016255
Gene Symbol: AOC2
1 Cross references
412 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSEEEG00000021758
Gene Symbol: APPB
4 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSEEEG00000018915
Gene Symbol: APP
4 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSEEEG00000018414
Gene Symbol: AGTR1
4 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).